Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 32, 2008 - Issue 4
75
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

Two New α-Thalassemia Point Mutations that are Undetectable by Biochemical Techniques

, , , , , , & show all
Pages 411-417 | Received 03 Dec 2007, Accepted 15 Jan 2008, Published online: 07 Jul 2009

REFERENCES

  • Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. HbVar: a relational database of human hemoglobin variants and thalassemia mutations of the globin gene server. Hum Mutat 2002; 19(3)225–233,
  • Patrinos GP, Giardine B, Riemer C, Miller W, Chui DHK, Anagnou NP, Wajcman H, Hardison RC. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 2004; 32(Database issue)D537–D541,
  • Higgs DR. Molecular mechanisms of α-thalassemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, MH Steinberg, BG Forget, DR Higgs, RL Nagel. Cambridge University Press, Cambridge 2001; 405–430
  • Lacan P, Kister J, Francina A, Souillet G, Galactéros F, Delaunay J, Wajcman H. Hemoglobin Debrousse [β96(FG3)Leu→Pro]: a new unstable hemoglobin with twofold increased oxygen affinity. Am J Hematol 1996; 51(4)276–281
  • Morlé F, Francina A, Ducrocq R, Wajcman H, Gonnet C, Philippe N, Souillet G, Godet J. A new α chain variant Hb Sallanches [α2 104(G11)Cys→Tyr] associated with Hb H disease in one homozygous patient. Br J Haematol 1995; 91(3)608–611
  • Lacan P, Becchi M, Zanella-Cleon I, Aubry M, Quinsat D, Couprie N, Francina A. Identification by mass spectrometry of a hemoglobin variant with an elongated β-globin chain. Clin Chem 2005; 51(1)213–215
  • Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood 2000; 95(1)360–362
  • Dodé C, Krishnamoorthy R, Lamb L, Rochette J. Rapid analysis of −α3.7 thalassaemia and αααanti 3.7 triplication by enzymatic amplification analysis. Br J Haematol 1992; 82(1)105–111
  • Perutz MF. Molecular anatomy and physiology of hemoglobin. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, MH Steinberg, BG Forget, DR Higgs, RL Nagel. Cambridge University Press, Cambridge 2001; 174–196
  • Yu X, Kong Y, Dore LC, Abdulmalik O, Katein AM, Zhou S, Choi JK, Gell D, Mackay JP, Gow AJ, Weiss MJ. An erythroid chaperone that facilitates folding of α-globin subunits for hemoglobin synthesis. J Clin Invest 2007; 117(7)1856–1865
  • Goossens M, Lee KY, Liebhaber SA, Kan YW. Globin structural mutant α125Leu→Pro is a novel cause of α-thalassaemia. Nature 1982; 296(5860)864–865
  • Darbellay R, Mach-Pascual S, Rose K, Graf J, Beris P. Haemoglobin Tunis-Bizerte: a new α1 globin 129 Leu→Pro unstable variant with thalassaemic phenotype. Br J Haematol 1995; 90(1)71–76
  • Harkness M, Harkness DR, Kutlar A, Wilson JB, Webber BB, Codrington JF, Huisman THJ. Hb Sun Prairie or α2130(H13)Ala→Proβ2, a new unstable variant occurring in low quantities. Hemoglobin 1990; 14(5)479–489
  • Wajcman H, Vasseur C, Blouquit Y, Rosa J, Labie D, Najman A, Reman O, Leporrier M, Galacteros F. Unstable α-chain hemoglobin variants with factitious β-thalassemia biosynthetic ratio: Hb Questembert (α131[H14]Ser→Pro) and Hb Caen (α132[H15]Val→Gly). Am J Hematol 1993; 42(4)367–374
  • Ayala S, Colomer, Aymerich M, Abella E, Vives Corrons JL. First description of a frameshift mutation in the α1-globin gene associated with α-thalassaemia. Br J Haematol 1997; 98(1)47–50
  • Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol 2003; 74(2)99–103
  • Viprakasit V, Tanphaichitr VS, Veerakul G, Chinchang W, Petrarat S, Pung-Amritt P, Higgs DR. Co-inheritance of Hb Pak Num Po, a novel α1 gene mutation, and α0-thalassemia associated with transfusion dependent Hb H disease. Am J Hematol 2004; 75(3)157–163
  • Salkie ML, Higgins T, Morrison DM, Wilson JB, Gu L-H, Curuk MA, Baysal E, Huisman THJ. A Canadian family with Hb Wayne; characterization by HPLC and DNA sequencing. Hemoglobin 1992; 16(6)515–519
  • Eng B, Patterson M, Walker L, Hoppe C, Azimi M, Lee H, Giordano PC, Waye JS. Three new α-thalassemia point mutations ascertained through newborn screening. Hemoglobin 2006; 30(2)149–153
  • Luo HY, Adewoye AH, Pilichowska M, Li MYL, Basran RK, Steinberg MH, Chui DHK. Two new α-thalassemia frameshift mutations. Hemoglobin 2007; 31(2)135–139
  • Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 2006; 14(10)1074–1081
  • Pereira FJC, Silva MDC, Picanço I, Seixas MT, Ferrão A, Faustino P, Romão L. Human α2-globin nonsense-mediated mRNA decay induced by a novel α-thalassaemia frameshift mutation at codon 22. Br J Haematol 2006; 133(1)98–102
  • Zhang J, Sun X, Qian Y, Maquat LE. Intron function in the nonsense-mediated decay of β-globin mRNA: indications that pre-mRNA slicing in the nucleus can influence mRNA translation in the cytoplasm. RNA 1998; 4(7)801–815
  • Liebhaber SA, Coleman MB, Adams JG, Cash FE, Steinberg MH. Molecular basis for nondeletion α-thalassemia in American blacks. α2(116GAG→UAG). J Clin Invest 1987; 80(1)154–159

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.